NAVIDEA BIOPHARMACEUTICALS, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

Item 2.02 Results of Operations and Financial Condition.

On May 11, 2021, Navidea Biopharmaceuticals, Inc. (the "Company") issued a press release regarding its consolidated financial results for the quarter ended March 31, 2021. A copy of the Company's May 11, 2021 press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information contained in Item 2.02 of this Current Report on Form 8-K, including exhibit 99.1 attached hereto, shall not be treated as "filed" for purposes of the Securities Exchange Act of 1934, as amended.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.



Exhibit
Number  Exhibit Description

99.1      Press Release dated May 11, 2021.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses